MDT vs. ELV, SNY, VRTX, SYK, REGN, BMY, GILD, ISRG, CI, and BSX
Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Elevance Health (ELV), Sanofi (SNY), Vertex Pharmaceuticals (VRTX), Stryker (SYK), Regeneron Pharmaceuticals (REGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Intuitive Surgical (ISRG), The Cigna Group (CI), and Boston Scientific (BSX). These companies are all part of the "medical" sector.
Medtronic (NYSE:MDT) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends.
80.8% of Medtronic shares are owned by institutional investors. Comparatively, 87.8% of Elevance Health shares are owned by institutional investors. 0.3% of Medtronic shares are owned by insiders. Comparatively, 0.4% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Medtronic has a net margin of 12.83% compared to Elevance Health's net margin of 3.49%. Elevance Health's return on equity of 20.47% beat Medtronic's return on equity.
Medtronic pays an annual dividend of $2.76 per share and has a dividend yield of 3.2%. Elevance Health pays an annual dividend of $5.92 per share and has a dividend yield of 1.2%. Medtronic pays out 89.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Elevance Health pays out 23.5% of its earnings in the form of a dividend.
Elevance Health has higher revenue and earnings than Medtronic. Elevance Health is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.
In the previous week, Medtronic had 6 more articles in the media than Elevance Health. MarketBeat recorded 21 mentions for Medtronic and 15 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.07 beat Medtronic's score of 0.80 indicating that Elevance Health is being referred to more favorably in the news media.
Medtronic currently has a consensus target price of $93.92, indicating a potential upside of 10.50%. Elevance Health has a consensus target price of $564.60, indicating a potential upside of 11.56%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Medtronic.
Medtronic received 759 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 76.63% of users gave Medtronic an outperform vote while only 66.29% of users gave Elevance Health an outperform vote.
Medtronic has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.
Summary
Elevance Health beats Medtronic on 11 of the 19 factors compared between the two stocks.
Get Medtronic News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medtronic Competitors List
Related Companies and Tools
